[1]
A. Ram, “Phloretin delays the progression of diabetic cataract by inhibiting lens aldose reductase enzyme and oxidative damage: In vitro and ex vivo experimental approaches”, IJAM, vol. 16, no. 4, pp. 958–962, Dec. 2025.